Niagen Bioscience earnings were $14.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NAGE earnings report on Mar 31, 2025 announced Q1 2025 earnings of $5.1M, down 29.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NAGE reported annual earnings of $8.6M, with -273.1% growth.
What were Niagen Bioscience's earnings last quarter?
On NAGE's earnings call on Invalid Date, Niagen Bioscience (NASDAQ: NAGE) reported Q1 2025 earnings per share (EPS) of $0.07, up 800% year over year. Total NAGE earnings for the quarter were $5.06 million. In the same quarter last year, Niagen Bioscience's earnings per share (EPS) was -$0.01.
As of the last Niagen Bioscience earnings report, Niagen Bioscience is currently profitable. Niagen Bioscience's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $14.11 million, a 499.8% decrease year over year.
What was NAGE's earnings growth in the past year?
As of Niagen Bioscience's earnings date in Invalid Date, Niagen Bioscience's earnings has grown year over year. NAGE earnings in the past year totalled $14.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.